» Articles » PMID: 7848306

Role of Interleukin-1, Tumor Necrosis Factor Alpha, and Interleukin-6 in Cartilage Proteoglycan Metabolism and Destruction. Effect of in Situ Blocking in Murine Antigen- and Zymosan-induced Arthritis

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 1995 Feb 1
PMID 7848306
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the involvement of interleukin-1 (IL-1), tumor necrosis factor (TNF), and IL-6 in the cartilage pathology of murine antigen-induced arthritis (AIA) and zymosan-induced arthritis (ZIA).

Methods: Arthritis was induced by intraarticular injection of zymosan in naive mice or by subcutaneous injection of methylated bovine serum albumin in sensitized animals. Mini-osmotic pumps releasing human recombinant IL-1 receptor antagonist (IL-1ra) protein were implanted intraperitoneally 2 days before arthritis induction, and neutralizing antibodies directed against murine IL-1 alpha, IL-1 beta, TNF alpha, or IL-6 were administered 1 day before. Proteoglycan (PG) synthesis and degradation were assessed in patellar cartilage.

Results: Murine IL-1 alpha and IL-1 beta injected intraarticularly at doses of 0.1-100 ng suppressed chondrocyte PG synthesis. The highest dose of TNF tested (100 ng) decreased PG synthesis marginally. In contrast, the maximum dose of IL-6 (1 microgram) stimulated PG synthesis 2 days after injection. Treatment of AIA with neutralizing monoclonal antibodies against either TNF alpha or IL-6 did not reduce either the PG degradation or the suppression of its synthesis. However, treatment with anti-IL-1 (alpha + beta) polyclonal antibodies totally prevented PG suppression, although the initial breakdown of PG was unaffected. This effect was confirmed when IL-1ra was administered in high doses. Moreover, treatment of ZIA with anti-IL-1 (alpha + beta), but not with anti-TNF, resulted in normal PG synthesis, confirming the key role played by IL-1 in the inhibition of PG synthesis. Treatment of AIA with anti-IL-1 did not affect inflammation during the acute phase, but a significant reduction of ongoing inflammation was noted at day 7, and there was a marked reduction in the loss of cartilage PG.

Conclusion: The suppression of PG synthesis in both ZIA and AIA in mice is due to the combined local action of IL-1 (alpha + beta), and neither IL-6 nor TNF is involved. Moreover, the normalization of PG synthesis brought about by blocking of IL-1 ameliorates the cartilage damage associated with AIA.

Citing Articles

The mode of action of IL-23 in experimental inflammatory arthritic pain and disease.

Lee K, Lupancu T, Chang L, Manthey C, Zeeman M, Fourie A Arthritis Res Ther. 2024; 26(1):148.

PMID: 39107827 PMC: 11302168. DOI: 10.1186/s13075-024-03380-z.


Osteoarthritis: Insights into Diagnosis, Pathophysiology, Therapeutic Avenues, and the Potential of Natural Extracts.

Coppola C, Greco M, Munir A, Musaro D, Quarta S, Massaro M Curr Issues Mol Biol. 2024; 46(5):4063-4105.

PMID: 38785519 PMC: 11119992. DOI: 10.3390/cimb46050251.


OSTF1 knockdown mitigates IL-1β-induced chondrocyte injury via inhibiting the NF-κB signaling pathway.

Hu B, Du G Heliyon. 2024; 10(9):e30110.

PMID: 38699012 PMC: 11064439. DOI: 10.1016/j.heliyon.2024.e30110.


The Impact of 45S5-Bioactive Glass on Synovial Cells in Knee Osteoarthritis-An In Vitro Study.

Platzer H, Marinescu M, Nawaz Q, Tripel E, Gantz S, Horsch A Materials (Basel). 2023; 16(24).

PMID: 38138736 PMC: 10745024. DOI: 10.3390/ma16247594.


Tocilizumab in Juvenile Idiopathic Arthritis Associated Uveitis, a Narrative Review.

Iannone C, Marelli L, Costi S, Pellico M, La Franca L, Caporali R Children (Basel). 2023; 10(3).

PMID: 36979992 PMC: 10047268. DOI: 10.3390/children10030434.